Supporting EcoPharmacoVigilance Transparency at AstraZeneca

As a result of patient use and manufacture, pharmaceuticals are found in the aquatic environment, typically in nanograms per litre concentrations. EcoPharmacoVigilance forms part of AstraZeneca’s approach to managing the safety of pharmaceuticals in the environment. The company conducts a robust environmental risk assessment for its products and reports a programme of safe discharge from …

Supporting EcoPharmacoVigilance Transparency at AstraZeneca Read More »

The Innovative PREMIER Database

Creating a Robust Architecture to Deliver Consistent Environmental Data to the Community. The PREMIER project will deliver a novel database and digital assessment system (DAS) for characterising the environmental risks of medicines and making environmental data more visible and accessible to industry, academia, regulators and the public. By making this valuable knowledge available to the …

The Innovative PREMIER Database Read More »

Introduction to the PREMIER Project

Simomics is delighted to announce that the Innovative Medicines Initiative (IMI), a partnership funded by the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA), has officially launched the project  “Prioritisation and Risk Evaluation of Medicines in the EnviRonment” (PREMIER) in September 2020. The PREMIER project …

Introduction to the PREMIER Project Read More »

Scroll to Top